Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / France

Research and Innovation Action · Running

PRISM Pediatric clinical Research Infrastructure Service Model

Coordinator
Ecrin European Clinical Research Infrastructure Network, France
Runs
1 September 2026 to 31 August 2030
Status
Running
EU funding
€10.0m
Total cost
€10.0m
Partners
23 organisations in 9 countries
Type
Research and Innovation Action
Grant agreement
101292607

What the project is doing

In the project's own words, from its summary on CORDIS.

In the PRISM project, professional clinical research infrastructures and service-oriented organisations will offer the paediatric clinical research community high-quality, leading-edge and coordinated TransNational Access (TNA) services for the design, planning and conduct of paediatric interventional or observational clinical studies. Services include end-to-end support for the design, planning and execution of multinational studies conducted in 3 to 6 countries in Europe and Canada (TNA1, WP1, 50% of total budget); consulting services for the planning and design of paediatric studies (TNA2, WP2) and virtual services (TNA3, WP4) on leading-edge methodologies, new trial designs (including platform trials, trials within cohorts, decentralised trials), and access to AI and digital tools, following final development and adaptation to paediatric needs (WP5).

Supported paediatric studies will be selected based on scientific excellence and public health relevance by an independent expert panel (WP3), with a two-stage procedure for the TNA1 allowing for support to the planning and design of short-listed projects between the first and second steps, thus optimising the final study protocol before execution. Training will be provided (WP7) for infrastructure staff involved in the development and provision of new services, and for the infrastructure users, i.e. paediatric research and investigation / rare diseases networks, and private or public sponsor teams.

Beyond the end of PRISM (WP6), its ambition is offering the paediatric research community coordinated services, avoiding duplication and promoting synergies, according to a mechanism agreed with all the relevant stakeholders in paediatric clinical research (infrastructures, technology providers, sponsors, investigation networks, patients) through contractual arrangements leading to a joint access mechanism.

Topics

Who is involved

OrganisationCityCountryRole
Ecrin European Clinical Research Infrastructure NetworkParisFranceCoordinator
Ainigma TechnologiesLeuvenBelgiumParticipant
European Network of Living Labs IvzwSint-Joost-ten-NodeBelgiumParticipant
Innovation SprintBruxelles / BrusselBelgiumParticipant
Universiteit GentGentBelgiumParticipant
MicyrnVancouver, British ColumbiaCanadaParticipant
Royal Institution for the Advancement of Learning Mcgill UniversityMontrealCanadaParticipant
Swiss Clinical Trial Organisation (scto)BernSwitzerlandParticipant
Universitat BaselBaselSwitzerlandParticipant
Universitats-Kinderspital Beider BaselBaselSwitzerlandThird party
Universitatsspital BaselBaselSwitzerlandThird party
Masarykova univerzitaBrnoCzechiaParticipant
Aristotelio Panepistimio ThessalonikisThessalonikiGreeceParticipant
Diadikasia Business Consulting Symvouloi Epicheiriseon AeAthinaGreeceParticipant
Erevnitiko Panepistimiako Institouto Systimaton Epikoinonion Kai YpologistonAthinaGreeceParticipant
Ethniko Kentro Erevnas Kai Technologikis AnaptyxisThermi ThessalonikiGreeceParticipant
Libra AI Technologies ANONYMI ETAIREIAAthensGreeceParticipant
Hospices Civils De LyonLyonFranceParticipant
PedstartLuynesFranceParticipant
XeetiNiceFranceParticipant
Universita Cattolica Del Sacro CuoreMilanoItalyParticipant
European School Heads AssociationUtrechtNetherlandsParticipant
Grampian Health BoardAberdeenUnited KingdomParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI